How healthy are your portfolio companies?
The CEPRES Healthcheck lets you make informed decisions.
In light of Covid-19, CEPRES has begun to offer free portfolio health checks to private equity firms and limited partners so they can see where their portfolios might be vulnerable. All portfolio companies will be affected differently, and CEPRES allows users to see that differentiation.
"Investors can see things like their margins and how Covid will impact their returns. It’s good to understand where the returns will come from. Some industries will suffer a lot, other industries like digital industries will do well. We can easily assess where your portfolio has risk.”
Daniel Schmidt, CEO & Managing Partner, CEPRES
Read the full article by Mergers & Acquisitions in here.
